1/34
RAHHHHH
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
List common symptoms of depression
-Presence of depressed mood
– Anhedonia
– Insomnia or hypersomnia
– Change in appetite or weight (>5%)
– Psychomotor retardation or agitation
– Low energy
– Poor concentration
– Thoughts of worthlessness or guilt
– Recurrent thoughts about death or suicide
Describe the first general theory of depression
Monamine Hypothesis: Depression results from reduced levels or impaired function of monoamine neurotransmitters (serotonin, dopamine, norepinephrine), leading to decreased monoaminergic signaling in the brain
Antidepressants often work by increasing monoamine availability
Describe the second general theory of depression
Neurotrophic Hypothesis: Depression is caused by decreased brain-derived neurotrophic factor (BDNF) and dysregulated cortisol, leading to reduced neuroplasticity (learning capability), impaired synaptic maintenance, and decreased neuronal resilience
Recall the major classes of antidepressants
Monoamine oxidase inhibitors (MAOI)
Tricyclic antidepressants (TCA)
Selective serotonin reuptake inhibitors (SSRI)
Selective serotonin-norepinephrine reuptake inhibitors (SNRI)
Atypical antidepressants
Novel antidepressants
Which monamines come from the precursors Tyrosine vs tryptophan?
Tyrosine → dopamine → norepinephrine
Tryptophan → serotonin
Compare and contrast characteristics of depression and anxiety
Depression: Characterized by persistent low mood, loss of interest or pleasure, low energy, feelings of hopelessness, and withdrawal from activities. It is often focused on the past or present and feels like emotional “shutdown.”
Anxiety: Characterized by excessive fear, worry, and physiological arousal (like racing heart, tension, restlessness). It is typically focused on the future, involving anticipation of threat or danger.
Differentiate between types of anxiety disorders
Generalized Anxiety Disorder (GAD)
Persistent, excessive worry about many different aspects of life that occurs most days for at least 6 months
Social Anxiety Disorder
Intense fear of social or performance situations due to worry about embarrassment, judgment, or rejection
Panic Disorder
Recurrent, unexpected panic attacks followed by ongoing fear of having more attacks
Specific Phobias: Flying, dentist, heights, blood
Strong, irrational fear of a specific object or situation that leads to avoidance behavior
PTSD
Anxiety disorder that develops after trauma and involves intrusive memories, avoidance, negative mood changes, and hyperarousal lasting over a month
Recall the major classes of anxiolytics
Fluoxetine (SSRI)
Venlafaxine (SNRI)
Buspirone (Azapirones)
Amitriptyline (Tricyclic)
Diazepam (Benzodiazepines)
Gabapentin (Antiepileptics)
Risperidone (Atypical Antipsychotics)
Mirtazapine (Alpha-2 antagonist)
Propranolol (Beta-blockers)
What are the positive symptoms of psychotic disorders?
An addition to perception
Hallucinations, delusions, feelings of persecution, agitation, combativeness, hyperactivity
What are the negative symptoms of psychotic disorders?
A subtraction to perception
Diminished emotional expression, decreased motivation, reduced speech, diminished ability to experience happiness, diminished interest in social interactions
What are the cognitive symptoms of psychotic disorders?
Disorganized thinking; derailment/unconnected tangents, answers to questions do not relate to the question, speech is incomphrensible
Explain which dopaminergic pathways contribute to which psychotic symptoms
Mesocortical Tract
Negative symptoms of schizophrenia
cort = cut out = negative
Mesolimbic tract
Positive and cognitive symptoms of schizophrenia
limb sounds like lit = positive (and cognitive)
Nigrostriatal Tract
Responsible for motor control
We don’t try to target this, accidentally targeted with drugs that target the above two
stri = stride = motor control
Tuberoinfundibular Tract
Increased prolactin release associated with side effects of antipsychotics
Antipsychotics increase prolactin release = many side-effects
tube = boob = prolactin
Medullary-periventricular Tracts
Change eating patterns, make patients gain weight
vent = need snacks = eating patterns
Explain the primary mechanism of action of antipsychotics, including dopamine D₂ receptor blockade and the role of serotonin receptor antagonism
Most antipsychotics are dopamine receptor antagonists
↓ dopamine activity, especially in mesolimbic pathway → improves positive symptoms (hallucinations, delusions)
Serotonin (5-HT₂A) antagonism (mainly atypicals):
Blocking 5-HT₂A → ↑ dopamine release in nigrostriatal pathway
This helps reduce EPS (motor side effects)
Also improves negative + cognitive symptoms
Explain typical antipsychotics in terms of what they treat and side effects
Treats: Treat positive symptoms
Side effects: High EPS risk, Low sedation, weight gain
Why EPS?
Dopamine regulates motor control, antagonizing it leads to less motor control
Explain atypical antipsychotics in terms of what they treat and side effects
Treats: Treat positive + negative + cognitive symptoms
Side effects: Low EPS, High metabolic effects (weight gain, diabetes-like issues), sedation, hypotension
IMPORTANT: Agranulocytosis can occur with weak D2 receptor antagonists and strong serotonin receptor antagonists like clozaine and olazapine
Identify the major adverse effects (and receptors responsible) of antipsychotics, including extrapyramidal symptoms and metabolic effects
D₂ Antagonism
Nigrostriatal pathway → EPS
Acute dystonia (early, painful spasms)
Tardive dyskinesia (late, often irreversible)
Tuberoinfundibular pathway → ↑ prolactin
Galactorrhea (milk production)
Breast swelling, endocrine disruption
Mesolimbic → ↓ pleasure
Mesocortical → worsens negative symptoms
H₁ (Histamine) Antagonism
Sedation
Weight gain
M₁ (Muscarinic) Antagonism
“Dry” effects:
Dry mouth
Constipation
Blurred vision
α₁ (Alpha-1 Adrenergic) Antagonism
Vasodilation
Postural hypotension
Dizziness, fainting
Explain how typical antipsychotics reduce their symptoms
Reduce positive symptoms via strong D2 antagonism of overactive dopamine release in the mesolimbic tract
Explain how atypical antipsychotics reduce their symptoms
Reduce positive symptoms via weak/partial D2 antagonism of overactive dopamine release in the mesolimbic tract
Reduce negative symptoms via serotonin antagonism to increase the amount of dopamine in the mesocortical tract
Reduce cognitive symptoms via serotonin antagonism to increase the amount of dopamine which is a smooth movement regulator in the nigrostrital tract
Differentiate between general anesthesia, local anesthesia, and analgesia
General Anesthesia: Induces temporary unconsciousness and affects whole body
Local Anesthesia: Numbs a small, specific area
Analgesia: Acts as pain relief without losing consciousness or total sensation
Explain the primary goals of general anesthesia
Analgesia: Loss of response to pain
Amnesia: Loss of memory
Immobility: Loss of motor, sensory, autonomic reflexes
Unconsciousness: Loss of consciousness
Skeletal muscle relaxation: Facilitates surgery
Explain the stages of anesthetic depth
Stage I (Analgesia): conscious, pain reduced, reflexes intact
Stage II (Excitement): unconscious but unstable, reflexes + movement + irregular breathing
Stage III (Surgical anesthesia): stable unconsciousness, reflexes gone, muscle relaxation, controlled breathing (goal stage)
Stage IV (Medullary depression): respiratory/cardiac failure, no reflexes, life-threatening overdose level
Explain blood:gas partition coefficient
Blood:Gas Partition Coefficient: How much anesthetic dissolves in blood vs stays in gas
High: More soluble in blood, dissolves and less reaches brain
Low: Less soluble in blood, more stays in blood as a gas and more reaches brain
Explain Minimal Alveolar Concentration (MAC)
Minimal Alveolar Concentration (MAC): % inhaled anesthetic needed to prevent movement/pain in 50% of patients
Explain how blood:gas partition coefficient and MAC relate to onset, recovery, and potency
Onset & recovery:
Controlled by blood:gas coefficient
High: Less reaches the brain, onset is longer, faster recovery
Low: More reaches the brain, faster onset, slower recovery
Potency:
Controlled by MAC
Low MAC = strong anesthetic (needs less drug)
High MAC = weaker anesthetic (needs more drug)
Differentiate between inhaled and intravenous anesthetics based on their mechanisms of action and pharmacokinetic properties.
Inhaled anesthetics: act mainly by enhancing CNS inhibition (↑GABA, ↓excitatory signaling); given via lungs; onset/recovery depend on blood:gas solubility; eliminated mostly unchanged via exhalation
IV anesthetics: directly act on CNS receptors (mainly ↑GABA); given IV for rapid brain delivery; duration depends on redistribution and metabolism (liver/plasma) rather than exhalation
Explain how intravenous anesthetics produce their effects, duration control, and time-sensitive half-time
IV anesthetics act directly on CNS receptors, inhibiting GABA-A receptors. This causes rapid loss of consciousness; effect is immediate because the drug goes straight to the brain via blood
Duration control: Emergence is due to redistribution (brain → muscle → fat) + metabolism via liver
Context-sensitive half-time:
Time for plasma concentration to drop by 50% after stopping an infusion
Increases with longer infusions because peripheral tissues (fat/muscle) become saturated and “leak” drug back into blood
So: short infusion = fast wake-up; long infusion = slower wake-up even for the same drug
Differentiate local anesthetics, neuromuscular junction blockers, and general anesthetics by their mechanisms and clinical effects
Local
Mechanism: Block voltage-gated Na⁺ channels → prevent action potential propagation in peripheral nerves
Clinical Effects: Cause localized loss of pain/sensation without affecting consciousness
NMJ:
Mechanism: Block nicotinic ACh receptors at NMJ (either depolarizing or competitive antagonism) → prevent muscle contraction
Clinical Effects: Cause skeletal muscle paralysis (no sedation, no analgesia)
General:
Mechanism: Depress CNS activity (↑ GABA_A receptor activity, ↓ excitatory signaling) → global neuronal inhibition
Clinical Effects: Cause unconsciousness, amnesia, analgesia, and muscle relaxation for surgery
Explain how local anesthetics block voltage-gated sodium channels to prevent action potential propagation and produce loss of sensation
Bind and block voltage-gated Na⁺ channels in peripheral nerves
Prevent Na⁺ influx → stop depolarization and action potential formation
No signal propagation along pain fibers → loss of sensation
Preferentially affect rapidly firing pain pathways first
Predict how drug properties and tissue conditions influence the onset, potency, and duration of local anesthetics.
↑ Lipid solubility → ↑ potency (better membrane penetration)
↑ Protein binding → ↑ duration (longer tissue retention)
Basic tissue → faster onset/more effective
Acidic tissue → slower/less effective
Vasoconstrictors ↓ blood flow → prolong duration
Compare depolarizing and non-depolarizing neuromuscular junction blockers based on their actions at the NMJ
Depolarizing: Binds and activates ACh receptor, causing persistent depolarization, leading to muscle twitches then paralysis
Non-Depolarizing: binds and does not activate Ach receptor, prevents depolarization leading to flaccid paralysis
Depolarizing = Short duration (rapid onset)
Non-depolarizing = Long duration
Neither provides sedation or analgesia
What are the mirtazapine sedation effects due to?
Increased norepinephrine/serotonin and antihistamine effects
What is the ion responsible for Benzodiazepin-induced neuronal inhibition?
Chloride
Benzos increase GABA which allows more chloride to enter neurons, neurons fire less and anxiety/seizures/insomnia back off